The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 7,782 | 6,657 | 6,091 | 6,834 |
| Accounts receivable | 94 | 799 | 935 | 797 |
| Inventories and other assets | 154 | -334 | 126 | 59 |
| Accounts payable and accrued expenses | 666 | 359 | 604 | -296 |
| Depreciation and amortization | 3,523 | 3,312 | 3,077 | 2,969 |
| Income taxes | 310 | 22 | 229 | 571 |
| Losses (gains) on sales of facilities | 37 | 14 | -5 | 1,301 |
| Losses on retirement of debt | - | 0 | 0 | -78 |
| Amortization of debt issuance costs | - | - | - | 29 |
| Amortization of debt issuance costs and discounts | 44 | 35 | 35 | - |
| Share-based compensation | 401 | 360 | 262 | 341 |
| Other | -195 | -248 | -189 | -153 |
| Net cash provided by operating activities | 12,636 | 10,514 | 9,431 | 8,522 |
| Purchase of property and equipment | 4,944 | 4,875 | 4,744 | 4,395 |
| Acquisition of hospitals and health care entities | 397 | 266 | 635 | 224 |
| Sales of hospitals and health care entities | 269 | 328 | 193 | 1,237 |
| Change in investments | -72 | 115 | 112 | -14 |
| Other | -12 | 5 | 19 | 21 |
| Net cash used in investing activities | -4,988 | -4,933 | -5,317 | -3,389 |
| Issuances of long-term debt | 8,474 | 7,495 | 3,224 | 5,997 |
| Net change in short-term borrowings and revolving credit facilities | 2,202 | -1,880 | -1,020 | 120 |
| Repayment of long-term debt | 7,389 | 2,410 | 909 | 2,830 |
| Distributions to noncontrolling interests | 827 | 711 | 640 | 1,025 |
| Payment of debt issuance costs | 79 | 67 | 31 | 53 |
| Payment of dividends | 679 | 690 | 661 | 653 |
| Repurchase of common stock | 10,067 | 6,042 | 3,811 | 7,000 |
| Other | -185 | -277 | -246 | -212 |
| Net cash used in financing activities | -8,550 | -4,582 | -4,094 | -5,656 |
| Effect of exchange rate changes on cash and cash equivalents | 9 | -1 | 7 | -20 |
| Change in cash and cash equivalents | -893 | 998 | 27 | -543 |
| Cash and cash equivalents at beginning of period | 1,933 | 935 | 908 | 1,451 |
| Cash and cash equivalents at end of period | 1,040 | 1,933 | 935 | 908 |
HCA Healthcare, Inc. (HCA)
HCA Healthcare, Inc. (HCA)